Egalet Corp. (EGLT) News Nov 20, 2014, 5:14 p.m.
Post# of 250602
Posted On: 11/20/2014 9:05:28 PM
Egalet Corp. (EGLT) News Nov 20, 2014, 5:14 p.m.
MarketWatch News on EGLT
Almost half of venture-backed IPOs this year are losers 5:00 a.m. Oct. 3, 2014 - Philip van Doorn
Other News on EGLT
FDA clears Purdue's abuse-deterrent opioid 1:36 p.m. Today - Seeking Alpha
10-Q: EGALET CORP 9:27 a.m. Nov. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Egalet's (EGLT) CEO Bob Radie on Q3 2014 Results - Earnings Call Transcript 12:18 p.m. Nov. 12, 2014 - Seeking Alpha
FDA clears Pfizer's abuse deterrent pain med 4:20 p.m. Oct. 17, 2014 - Seeking Alpha
Egalet (EGLT) Shows Strength: Stock Moves 7.1% Higher - Tale of the Tape 8:46 a.m. Oct. 13, 2014 - Zacks.com
Egalet drops after disclosure on abuse deterrent morphine product candidate 1:09 p.m. Sept. 24, 2014 - Seeking Alpha
Falling Earnings Estimates Signal Weakness Ahead for Egalet (EGLT) - Tale of the Tape 7:46 a.m. Aug. 20, 2014 - Zacks.com
10-Q: EGALET CORP 2:00 p.m. Aug. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Egalet's (EGLT) CEO Bob Radie on Q2 2014 Results - Earnings Call Transcript 11:37 p.m. Aug. 12, 2014 - Seeking Alpha
10-Q: EGALET CORP 2:05 p.m. May 15, 2014 - Edgar Online - (EDG = 10Q, 10K)
Press Releases on EGLT
Egalet Reports Third Quarter 2014 Financial Results and Provides Business Update 6:00 a.m. Nov. 12, 2014 - PR Newswire - PRF
Egalet to Present at the Stifel 2014 Healthcare Conference on November 18 8:31 a.m. Nov. 5, 2014 - GlobeNewswire
Egalet to Host Conference Call and Webcast to Discuss Third Quarter Financial Results on November 12, 2014 7:30 a.m. Oct. 29, 2014 - PR Newswire - PRF
Egalet Announces Update on Clinical Development Plan for Abuse-Deterrent Morphine Egalet-001 3:01 p.m. Sept. 23, 2014 - GlobeNewswire
Egalet Announces Issuance of U.S. Patents Covering Guardian(TM) Technology and Product Candidates 7:01 a.m. Sept. 11, 2014 - GlobeNewswire
Egalet to Present Data from Abuse-Deterrence Studies at PAINWeek 2014 in Las Vegas 7:36 a.m. Sept. 4, 2014 - GlobeNewswire
Egalet Announces Successful End-of-Phase 2 Meeting With the FDA for Egalet-002 7:01 a.m. Aug. 18, 2014 - GlobeNewswire
Egalet Reports Second Quarter 2014 Financial Results and Provides Business Update 5:00 a.m. Aug. 12, 2014 - PR Newswire - PRF
Egalet Announces Topline Results From Bioequivalence Studies of Abuse-Deterrent Morphine, Egalet-001 5:01 a.m. Aug. 6, 2014 - GlobeNewswire
Egalet to Present at the Canaccord Genuity Growth Conference on August 13 7:31 a.m. July 30, 2014 - GlobeNewswire
Egalet to Host Conference Call and Webcast to Discuss Second Quarter Financial Results on August 12, 2014 8:30 a.m. July 29, 2014 - PR Newswire - PRF
Egalet Appoints Jeffrey M. Dayno, M.D. as Chief Medical Officer 7:31 a.m. July 28, 2014 - GlobeNewswire
Egalet Reports Positive Top-Line Results From Category 1 Abuse Deterrence Studies Demonstrating Egalet-001 Resists Physical and Chemical Manipulation 7:34 a.m. July 15, 2014 - GlobeNewswire
Egalet to Present at Upcoming Investor Conferences in June 7:02 a.m. May 22, 2014 - GlobeNewswire
Egalet to Host Conference Call and Webcast to Discuss First Quarter 2014 Financial Results on May 13, 2014 7:00 a.m. April 29, 2014 - PR Newswire - PRF
Egalet Corporation [EGLT] to Ring The NASDAQ Stock Market Opening Bell 9:01 a.m. April 23, 2014 - GlobeNewswire
Egalet to Present at the 13th Annual Needham Healthcare Conference on April 9 8:44 a.m. April 2, 2014 - GlobeNewswire
Egalet Added to Russell 3000, Russell 2000 and Russell Global Indexes 8:26 a.m. April 1, 2014 - GlobeNewswire
Egalet Reports Positive Outcome of First Phase of Category 1 Abuse Deterrence Studies for Egalet-001 7:15 a.m. March 31, 2014 - GlobeNewswire
Egalet Reports Full Year 2013 Financial Results and Provides Business Update 6:00 a.m. March 26, 2014 - PR Newswire - PRF
MarketWatch News on EGLT
Almost half of venture-backed IPOs this year are losers 5:00 a.m. Oct. 3, 2014 - Philip van Doorn
Other News on EGLT
FDA clears Purdue's abuse-deterrent opioid 1:36 p.m. Today - Seeking Alpha
10-Q: EGALET CORP 9:27 a.m. Nov. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Egalet's (EGLT) CEO Bob Radie on Q3 2014 Results - Earnings Call Transcript 12:18 p.m. Nov. 12, 2014 - Seeking Alpha
FDA clears Pfizer's abuse deterrent pain med 4:20 p.m. Oct. 17, 2014 - Seeking Alpha
Egalet (EGLT) Shows Strength: Stock Moves 7.1% Higher - Tale of the Tape 8:46 a.m. Oct. 13, 2014 - Zacks.com
Egalet drops after disclosure on abuse deterrent morphine product candidate 1:09 p.m. Sept. 24, 2014 - Seeking Alpha
Falling Earnings Estimates Signal Weakness Ahead for Egalet (EGLT) - Tale of the Tape 7:46 a.m. Aug. 20, 2014 - Zacks.com
10-Q: EGALET CORP 2:00 p.m. Aug. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Egalet's (EGLT) CEO Bob Radie on Q2 2014 Results - Earnings Call Transcript 11:37 p.m. Aug. 12, 2014 - Seeking Alpha
10-Q: EGALET CORP 2:05 p.m. May 15, 2014 - Edgar Online - (EDG = 10Q, 10K)
Press Releases on EGLT
Egalet Reports Third Quarter 2014 Financial Results and Provides Business Update 6:00 a.m. Nov. 12, 2014 - PR Newswire - PRF
Egalet to Present at the Stifel 2014 Healthcare Conference on November 18 8:31 a.m. Nov. 5, 2014 - GlobeNewswire
Egalet to Host Conference Call and Webcast to Discuss Third Quarter Financial Results on November 12, 2014 7:30 a.m. Oct. 29, 2014 - PR Newswire - PRF
Egalet Announces Update on Clinical Development Plan for Abuse-Deterrent Morphine Egalet-001 3:01 p.m. Sept. 23, 2014 - GlobeNewswire
Egalet Announces Issuance of U.S. Patents Covering Guardian(TM) Technology and Product Candidates 7:01 a.m. Sept. 11, 2014 - GlobeNewswire
Egalet to Present Data from Abuse-Deterrence Studies at PAINWeek 2014 in Las Vegas 7:36 a.m. Sept. 4, 2014 - GlobeNewswire
Egalet Announces Successful End-of-Phase 2 Meeting With the FDA for Egalet-002 7:01 a.m. Aug. 18, 2014 - GlobeNewswire
Egalet Reports Second Quarter 2014 Financial Results and Provides Business Update 5:00 a.m. Aug. 12, 2014 - PR Newswire - PRF
Egalet Announces Topline Results From Bioequivalence Studies of Abuse-Deterrent Morphine, Egalet-001 5:01 a.m. Aug. 6, 2014 - GlobeNewswire
Egalet to Present at the Canaccord Genuity Growth Conference on August 13 7:31 a.m. July 30, 2014 - GlobeNewswire
Egalet to Host Conference Call and Webcast to Discuss Second Quarter Financial Results on August 12, 2014 8:30 a.m. July 29, 2014 - PR Newswire - PRF
Egalet Appoints Jeffrey M. Dayno, M.D. as Chief Medical Officer 7:31 a.m. July 28, 2014 - GlobeNewswire
Egalet Reports Positive Top-Line Results From Category 1 Abuse Deterrence Studies Demonstrating Egalet-001 Resists Physical and Chemical Manipulation 7:34 a.m. July 15, 2014 - GlobeNewswire
Egalet to Present at Upcoming Investor Conferences in June 7:02 a.m. May 22, 2014 - GlobeNewswire
Egalet to Host Conference Call and Webcast to Discuss First Quarter 2014 Financial Results on May 13, 2014 7:00 a.m. April 29, 2014 - PR Newswire - PRF
Egalet Corporation [EGLT] to Ring The NASDAQ Stock Market Opening Bell 9:01 a.m. April 23, 2014 - GlobeNewswire
Egalet to Present at the 13th Annual Needham Healthcare Conference on April 9 8:44 a.m. April 2, 2014 - GlobeNewswire
Egalet Added to Russell 3000, Russell 2000 and Russell Global Indexes 8:26 a.m. April 1, 2014 - GlobeNewswire
Egalet Reports Positive Outcome of First Phase of Category 1 Abuse Deterrence Studies for Egalet-001 7:15 a.m. March 31, 2014 - GlobeNewswire
Egalet Reports Full Year 2013 Financial Results and Provides Business Update 6:00 a.m. March 26, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼